Fig. 7From: ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinomaISG15 elevation-induced destabilization of PD-L1 improve PD-L1-targeted immunotherapyBack to article page